To further investigate the anti-AD effects of Eri and Hom through inhibition of the NLRP3 inflammasome, N9 microglia were subjected to in vitro experiments with the addition of nigericin, which is an agonist of the NLRP3 inflammasome [54,55]. This evidence concerns the gene NLRP3 and Alzheimer disease.